CA
ANAC

Corrado Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Corrado Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,015
Closed -$465K – 78
2014
Q3 		$465K Sell
19,015
-825
-4% -$16.8K 0.21% 51
2014
Q2 		$352K Sell
19,840
-8,600
-30% -$138K 0.15% 56
2014
Q1 		$569K Buy
+28,440
New +$551K 0.28% 46

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corrado Advisors's ANAC Position: Q4 2014 in Review

Corrado Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 19,015 shares — an estimated $465K sold.

Corrado Advisors first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $569K in Q1 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

  • Corrado Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
  • Corrado Advisors sold 19,015 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $465K.
  • Corrado Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
  • Corrado Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $569K in Q1 2014.
  • 147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on Corrado Advisors's 13F filing for Q4 2014, filed 12 Jan 2015.